France: The French implementation of the EU trademarks directive

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

France: The French implementation of the EU trademarks directive

ip-policy-ghana-min-final.jpg

Order No 2019-1169 of November 13 2019 relating to trademarks incorporates Directive (EU) 2015/2436 of December 16 2015 and was published on November 14 2019.

It entered into force on December 11, with the exception of the provisions relating to invalidity and revocation procedures (these will enter into force on April 2020).

As a result of this new law, the requirement of graphic representation is no longer necessary. The absolute grounds for refusal now encompass appellations of origin, geographical indications, traditional terms for wine and traditional specialties, and earlier plant variety denominations. The provisions relating to collective trademarks have also been amended. Only applications filed from the entry into force of the order are affected.

The opposition procedure is now available for prior rights, including company names, commercial names and domain names, reputed trademarks, names, images of a public entity and trademarks filed in their own name by an agent or representative. Several earlier rights may be invoked. When applicable, proof must be provided for the five year period preceding the application date of the opposed trademark for the goods or services which serve as the basis of the opposition.

Procedural rules are also amended. These new rules concern trademark applications filed as of December 11 2019.

The FPTO will have now exclusive jurisdiction regarding actions based on absolute grounds or invalidity for non-use. The office will share jurisdiction with courts regarding actions based on relative grounds. The courts remain competent when there is a connected issue of unfair competition and in relation to infringement actions, investigative, interim or provisional measures. The action before the FPTO could be based on several grounds and/or rights.

This action will be inadmissible if, upon the request of the defendant, the opposing party cannot prove that his trademark was in use during the five year period preceding the action. He needs to prove that his trademark was used during the five year period preceding the application date of the later trademark and his trademark was registered for more than five years before this application date.

There is no limitation period attached to the invalidity action except for well-known trademarks. However, tolerance of use of the later registration for five years will make the action inadmissible.

The infringement action is extended to the offer, the placing on the market or the notable possession of packaging, labels, marks or any other support on which the trademark is attached and to merchandise in transit. The limitation period for infringement actions will now be five years from the day the right holder knew or should have known the last fact enabling him to exercise his right.

New official fees are also applicable from December 11.

Aurélia Marie

more from across site and SHARED ros bottom lb

More from across our site

VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
With rankings for Western Europe set to be published on June 25, we sat down with our research lead to find out what practitioners and law firms can expect
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Matteo Di Lernia, advocate at LCA Studio Legale, unpicks the CJEU’s ruling in M.M. Ristorazione v Villa Ramazzini, including its impact on litigation strategies
Gift this article